Browse Category

SGX:G13.SI News 10 December 2025 - 14 January 2026

Genting Singapore (G13.SI) Share Price, Latest News and 2026 Stock Forecast After Moody’s Downgrade

Genting Singapore (G13.SI) Share Price, Latest News and 2026 Stock Forecast After Moody’s Downgrade

SINGAPORE – 10 December 2025 – Genting Singapore Limited, the operator of Resorts World Sentosa and one of the Straits Times Index’s most watched consumer names, is back in the spotlight after a fresh credit rating downgrade at group level – even as earnings recover, tourism rebounds and analysts project double‑digit upside for the stock. Genting Singapore share price today: trading around S$0.73 Genting Singapore’s share price is trading in the low‑70 Singapore cents range on 10 December 2025. SGinvestors quotes the counter at S$0.735 as of 14:28 SGT, while Beansprout shows S$0.725 earlier in the session, implying modest intraday
10 December 2025

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
New York, Feb 7, 2026, 11:05 EST — Market closed. Costco Wholesale Corp (COST.O) closed Friday up 1.2% at $1,001.16, clawing back above the $1,000 mark into the weekend. The stock ranged from $982.30 to $1,001.20 and traded about 2.36 million shares, with U.S. markets shut on Saturday. The move matters because Costco has become a quick read on the steadier end of U.S. consumer spending, and it is landing right as investors try to sort out whether rates are headed down again — and what that does to big, expensive retail names. A consumer snapshot on Friday did not
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop